INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $43,605 | -74.8% | 13,500 | -89.6% | 0.00% | -100.0% |
Q2 2016 | $173,000 | -74.7% | 130,000 | 0.0% | 0.00% | -75.0% |
Q1 2016 | $685,000 | +22733.3% | 130,000 | +48407.5% | 0.00% | – |
Q2 2015 | $3,000 | -98.7% | 268 | -98.1% | 0.00% | -100.0% |
Q4 2014 | $233,000 | -80.4% | 13,804 | -84.0% | 0.00% | -87.5% |
Q4 2013 | $1,191,000 | -58.5% | 86,295 | -47.5% | 0.01% | -71.4% |
Q3 2013 | $2,867,000 | -38.1% | 164,521 | -42.5% | 0.03% | -44.0% |
Q2 2013 | $4,629,000 | – | 285,885 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |